Strategic clinical and pharmaceutical research leader with a history of driving scientific and commercial success and building effective teams and partnerships • Team-oriented, results-driven leader with extensive experience in multiple therapeutic areas • Adept manager of multiple projects with dynamic prioritization • Extensive knowledge in clinical research and development • Experienced collaborator: evaluated, initiated, and contributed to productive collaborations with multiple academic institutions and CROs • Excellent technical writing skills: authored and co-authored eight peer-reviewed scientific articles as well as posters, reports, SOPs, IACUC protocols, proposals, and white papers • Effective communicator with excellent interpersonal skills Specialties: Biomedical research (including cell culture, basic molecular biology techniques), genetically engineered mouse models, Stem Cells, CNS disease (including Huntington's disease, Alzheimer's disease, HIV-associated dementia, ALS), metabolic disease, Immunology, Target identification & validation, internal/external collaborations

Associate Director, Clinical Strategy & Development @ From November 2014 to Present (1 year 2 months) Visiting Researcher @ From November 2013 to July 2015 (1 year 9 months) Medical Science Liaison & Key Account Manager @ • Identify, establish, and maintain clinical and scientific relationships with global KOLs in both academic, industry and community settings as participants of advisory boards to discuss key client’s developing products and other medical/scientific topics of interest • Provide clinical and scientific presentation support o Facilitating external scientist speaker trainings o Creating disease sate and product-related slide sets for key clients and internal needs • Manage global scientific advisory boards for key clients • Identify KOLs for investigator-initiated studies • Obtain input from KOLs and subject matter expertise (SMEs) for phase I-III trials • Communicate key scientific rationale and provide scientific support to business development team • Advise Profil on scientific path forward • Develop key account & project management expertise and capacities at Profil • Closely collaborates with multifunctional areas in developing and establishing Profil’s consulting services • Act as the first line of contact with clients and various Profil or client consultants and advisors • Identify necessary resources and work in close cooperation with the financial services department to manage strategic accounts effectively From January 2014 to October 2014 (10 months) Research Scientist II @ Project team leader for establishing in vitro models of Huntington’s disease (HD) and generating iPSC-derived neuroprogenitor cell lines for drug discovery o Established and managed human stem cell laboratory o Designed, directed and executed work flow in stem cell lab creating efficient research environment o Generated and characterized iPSC lines using HD patient fibroblasts that were utilized for HD disease modeling and drug discovery o Established protocols to differentiate human pluripotent stem cells (hPSC) to CNS lineages with higher efficiencies than any previously published protocol o Developed protocol for scale up hPSC-derived neuroprogenitor cells, neurons, and glia cells capable for HTS o Directed research activities aimed at establishing efficacy models to test hit compounds o Initiated new target identification and drug discovery programs for HD by developing various cell based assays o Participated in organization of HD and CNS regeneration advisory board • Provided intellectual and technical expertise to internal CNS related project (Pain, ALS and multiple sclerosis) teams • Evaluated and supported collaborations on SMA and Parkinson’s disease with academic institutions and CROs • Supervised and trained scientists, research associates, and student interns From 2009 to 2013 (4 years) Postdoctoral fellow @ Lead researcher on multiple projects: 1) Neuroprotective effects of erythoropoietin/IGF-I, nitromemantine, and cytokines in a mouse model of HIV-associated dementia and Alzheimer’s disease 2) Investigation of the genome-wide DNA targets of MEF2C transcription factor in human embryonic stem cell (hESC)-derived neural progenitor cells o Designed, implemented, and troubleshot complex research projects from inception through publication o Motivated colleagues and collaborators toward achieving a common goal, resulting in the publication of five primary research articles o Presented findings regularly to principal investigator, colleagues, and at scientific conferences o Supervised and directed undergraduate students From 2009 to 2009 (less than a year) Postdoctoral Associate @ Lead researcher on multiple projects: 1) Neuroprotective effects of erythoropoietin/IGF-I, nitromemantine, and cytokines in a mouse model of HIV-associated dementia and Alzheimer’s disease 2) Investigation of the genome-wide DNA targets of MEF2C transcription factor in human embryonic stem cell (hESC)-derived neural progenitor cells o Designed, implemented, and troubleshot complex research projects from inception through publication o Motivated colleagues and collaborators toward achieving a common goal, resulting in the publication of five primary research articles o Presented findings regularly to principal investigator, colleagues, and at scientific conferences o Supervised and directed undergraduate students From 2006 to 2009 (3 years) Postdoctoral fellow @ • Conducted research on transcriptional regulation of prostaglandin endoperoxide H synthase (PGHS)-2 in a macrophage model of inflammation – Work published • Reviewed scientific papers for Journal of Biological Chemistry. From 2006 to 2006 (less than a year)

Ph.D., Cell and Molecular Biology @ Michigan State University From 2001 to 2005 Yeonjoo Kang is skilled in: Drug Discovery, Cell Biology, Molecular Biology, Animal Models, Biochemistry, Assay Development, Western Blotting, Target Identification, Immunology, Neuroscience, Stem Cell Research, Immunohistochemistry, qPCR, Molecular Cloning, Mammalian Cell Culture